Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

D-Valneb 250 Tablet ER

Prescription Icon
Prescription Required

Marketer

Kachhela Medex Pvt Ltd

Salt Composition

Divalproex (250mg)

Overview D-Valneb 250 Tablet ER

Valneba XR 250mg extended-release tablets are prescribed for epilepsy management, preventing and controlling seizures. They're also indicated for migraine prophylaxis and, in some cases, bipolar disorder treatment. Valneba XR 250mg may be administered alone or concurrently with other medications; dosage and frequency are determined by your physician to optimize symptom control. This medication can be taken with or without food, but consistent daily timing is crucial for efficacy. Therapeutic effects generally manifest within a few weeks. Continuous use, as directed, is essential; missed doses risk seizure recurrence, and abrupt cessation can worsen your condition. Discontinuation should always be gradual. Common side effects include headache, blurred vision, nausea, vomiting, dizziness, fatigue, imbalance, easy bruising, and hypothermia. While most are mild, persistent or bothersome effects warrant medical consultation. Report any skin rash or redness immediately. Prolonged use may cause osteoporosis, increasing fracture risk, and rarely, suicidal ideation or behavior. Report any depressive symptoms to your doctor. Prior to commencing treatment, inform your physician of any history of heart disease, renal or hepatic impairment, urinary difficulties, depression, or suicidal tendencies. Drug interactions are possible; disclose all current medications to ensure safety. Consult your physician before initiating or discontinuing Valneba XR 250mg during pregnancy. Alcohol consumption should be avoided due to potential side effect exacerbation and increased seizure risk. Regular blood monitoring, both pre- and post-treatment initiation, may be necessary for optimal dosage adjustment.

Uses of D-Valneb 250 Tablet ER

Managing epileptic seizures and bipolar disorder; migraine prevention.

Major Benefits of D-Valneb 250 Tablet ER:

Administer this medication precisely as directed by your physician, adhering to the prescribed dosage and treatment schedule. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. D-Valneb 250 Extended-Release Tablets may be consumed with or without food, however, consistent daily timing is recommended.

Common Side effects of D-Valneb 250 Tablet ER:

  • Decreased body temperature
  • Dizziness
  • Sleepiness
  • Tremors
  • Paresthesia (tingling or pricking sensation)
  • Anemia (low number of red blood cells)
  • Decreased sodium level in blood
  • Liver injury
  • Gastrointestinal disturbance
  • Hypersensitivity
  • Deafness
  • Urinary incontinence
  • Increase in body weight
  • Pain during periods

How to use D-Valneb 250 Tablet ER:

Administer this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment period. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. D-Valneb 250 Extended-Release Tablets can be consumed with or without food, though consistent timing is recommended.

How D-Valneb 250 Tablet ER works:

Extended-release D-Valneb 250 mg tablets are used to manage epilepsy. Their mechanism of action involves reducing hyperactive neuronal firing in the brain, thus controlling seizures.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Taking D-Valneb 250 Extended-Release tablets with alcohol can lead to significant sleepiness.

PregnancyPregnancyCONSULT YOUR DOCTOR

Extended-release D-Valneb 250mg tablets pose a confirmed risk to fetal development and should not be taken during pregnancy. In exceptional, life-threatening circumstances, a physician might prescribe it if the potential benefits outweigh the known hazards. Physician consultation is essential.

Breast feedingBreast feedingSAFE IF PRESCRIBED

Extended-release D-Valneb 250mg tablets are considered safe for use while breastfeeding. Research in humans indicates minimal drug transfer into breast milk, posing no known risk to the infant.

DrivingDrivingUNSAFE

Extended-release D-Valneb 250mg tablets can induce adverse reactions that might impair driving capabilities.

KidneyKidneySAFE IF PRESCRIBED

Extended-release D-Valneb 250 mg tablets are considered safe for use in individuals with kidney impairment. No alteration of the D-Valneb 250 mg extended-release tablet dosage is necessary.

LiverLiverUNSAFE

Extended-release D-Valneb 250 mg tablets are likely contraindicated for individuals with hepatic impairment and should be omitted. Physician consultation is advised.

What if you forget to take D-Valneb 250 Tablet ER :

Should you forget a dose of D-Valneb 250 Tablet ER, administer it at your earliest convenience. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About D-Valneb 250 Tablet ER

LabelValue
Chemical Classification Derivatives of Aliphatic Carboxylic Acids
Developing Habits No.
Treatment Category Neuroscience and Central Nervous System
Behavioral Class Antiepileptic drugs targeting sodium channels

FAQs on D-Valneb 250 Tablet ER

Always consult your doctor before discontinuing D-Valneb 250 Tablet ER. Withdrawal should be gradual and supervised to minimize the risk of symptom recurrence, including irritability, anxiety, dizziness, and tremors.
D-Valneb 250 Tablet ER may be used to stabilize mood in patients experiencing rapid mood swings. Its mechanism involves reducing excessive brain activity associated with these mood changes.
Weight gain is a possible side effect of D-Valneb 250 Tablet ER, potentially stemming from increased appetite. To manage this, maintain a healthy diet and exercise regularly. Consult your doctor if weight gain is a concern.
D-Valneb 250 Tablet ER can cause drowsiness. Refrain from driving or activities requiring alertness until you understand its effects.
Hair loss is a possible, though typically temporary and dose-dependent, side effect of D-Valneb 250 Tablet ER. Contact your doctor if this side effect concerns you or continues.
D-Valneb 250 Tablet ER can cause liver damage, particularly within the first six months of treatment. Symptoms of this may include nausea, vomiting, appetite loss, stomach pain, dark urine, facial swelling, and jaundice (yellowing of skin or eyes). Liver function tests are recommended before starting, and regularly during the initial six months, especially for at-risk individuals or those with pre-existing liver conditions.
Refrain from alcohol during your D-Valneb 250 Tablet ER treatment. Combining alcohol with this medication may increase drowsiness, lightheadedness, or dizziness.
Before starting D-Valneb 250 Tablet ER, your doctor might recommend blood tests. These may include a complete blood count (with platelet count), bleeding time, and coagulation tests to minimize the risk of bleeding or bruising. Liver function tests are also advised before, and regularly monitored during the first six months of treatment, especially for patients with a history of liver problems or those considered high-risk.
Severe abdominal pain, nausea, and vomiting may indicate pancreatitis. Seek immediate medical attention if you experience these symptoms. Your doctor may order a serum amylase test; a positive result requires immediate medication cessation.
D-Valneb 250 Tablet ER overdose can lead to headaches, blurred vision (from constricted pupils), reduced reflexes, confusion, and fatigue. Further symptoms may include muscle weakness, seizures, loss of consciousness, altered behavior, and respiratory problems like rapid breathing, shortness of breath, or chest pain. Seek immediate medical help if an overdose occurs.
D-Valneb 250 Tablet ER
69
MRP 84
17% off